Skip to content

USA
Business
Entertain
Health
Science
Sports
Tech
World

USA
Business
Entertain
Health
Science
Sports
Tech
World

clinical trial

DOST OK with clinical trial to test ivermectin versus COVID-19

DOST OK with clinical trial to test ivermectin versus COVID-19

NIH study of anti-CD14 antibody to treat COVID-19 respiratory disease begins

NIH study of anti-CD14 antibody to treat COVID-19 respiratory disease begins

The benefits of microdosing could be largely placebo, experimental research suggests

The benefits of microdosing could be largely placebo, experimental research suggests

The benefits of microdosing could be largely placebo, experimental research suggests

The benefits of microdosing could be largely placebo, experimental research suggests

Four Potential COVID-19 Therapies Enter Phase 2/3 Trial in NIH ACTIV-2 Trial

Four Potential COVID-19 Therapies Enter Phase 2/3 Trial in NIH ACTIV-2 Trial

Intranasal flu vaccine stimulates strong immune response in phase 1 study

Intranasal flu vaccine stimulates strong immune response in phase 1 study

Full dose blood thinners reduced life support need and improved outcome in hospitalized COVID-19 patients

Combination treatment for methamphetamine use disorder shows promise in NIH study

Combination treatment for methamphetamine use disorder shows promise in NIH study

Novavax’s COVID-19 vaccine is the latest to participate in the Phase 3 study in the US.

Novavax’s COVID-19 vaccine is the latest to participate in the Phase 3 study in the US.

NIH ACTIV study of blood thinners pauses enrollment of critically ill COVID-19 patients

footer

Contact Us
Sitemap
Sitemap-News

© 2025 ABC7.News